A new era in melanoma immunotherapy: focus on DCs metabolic reprogramming

A new era in melanoma immunotherapy: focus on DCs metabolic reprogramming

Abstract Melanoma, being one of the most dangerous forms of skin cancer, is characterized by its aggressive and metastatic nature, with the potential to develop resistance to various treatments. This resistance makes the disease challenging to treat, emphasizing the need for new treatment strategies...

Full description

Saved in:
Bibliographic Details
Main Authors: Mina Afrashteh Nour, Mansour Rajabivahid, Marjan Sadat Seyed Mehdi, Safa Tahmasebi, Sepideh Nasirzadeh Dashtgol, Mahmoud Dehghani-Ghorbi, Ahmad Ghorbani Vanan, Farid Ghorbaninezhad
Format: Article
Language:English
Published: BMC 2025-04-01
Series:Cancer Cell International
Subjects:
Dendritic cell
Melanoma
Metabolic reprogramming
Tumor microenvironment
Immunotherapy
Online Access:https://doi.org/10.1186/s12935-025-03781-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12935-025-03781-3

Similar Items